Nanobody-drug conjugates for targeting specific GPCR pairs
PLOS Biology · 2025
DOI: 10.1371/journal.pbio.3003483 ↗Kurz gefasst
Kommentar in der Zeitschrift PLOS Biology, 2025. Verfasst von Xianglin Huang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Single-Domain Antibodies. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
ORCID-Profile: Xianglin Huang, Bryan L Roth
Zitieren
APA
Huang, X., & Roth, B. L. (2025). Nanobody-drug conjugates for targeting specific GPCR pairs. PLOS Biology. https://doi.org/10.1371/journal.pbio.3003483
Vancouver
Huang X, Roth BL. Nanobody-drug conjugates for targeting specific GPCR pairs. PLOS Biology. 2025. doi:10.1371/journal.pbio.3003483
BibTeX
@article{Huang2025,
author = {Huang, Xianglin and Roth, Bryan L},
title = {Nanobody-drug conjugates for targeting specific GPCR pairs},
journal = {PLOS Biology},
year = {2025},
doi = {10.1371/journal.pbio.3003483}
}
EUVIMED